Verantwoord innoveren

GMO safety
Synthetic biology
Adaptive Risk Assessment

Due to developments in modern biotechnology, such as genome editing, synthetic biology and regulation of gene expression, many new applications are expected in the next ten years. The method that is currently used for the assessment of risks for human health and the environment does not seem to be equipped for all future developments. These were the findings of a report by RIVM .


Source: RIVM, 28 May 2018.


​​ Kantoor:
+31 (0)343 51 47 61
+31 (0)6 238 68 017

Diederichslaan 25
3971 PA Driebergen